Abstract
Urinary protein and calcium excretion were assessed in 77 patients with the hepatic glycogen storage diseases (GSD): 30 with GSD-I (median age 12.4 years, range 3.2–32.9 years), 25 with GSD-III (median age 10.5 years, range 4.2–31.3 years) and 22 with GSD-IX (median age 11.8 years, range 1.2–35.4 years). Inulin (C inulin) and para-aminohippuric acid (C PAH) clearances were also measured in 33 of these patients. Those with GSD-I had significantly greater albumin (F=15.07,P<0.001), retinolbinding protein (RBP) (F=14.66,P<0.001),N-acetyl-β-d glucosaminidase (NAG) (F=9.41,P<0.001) and calcium (F=7.41,P=0.001) excretion than those with GSD-III and GSD-IX. GSD-I patients (n=18) also had significantly higherC inulin (F=5.57,P=0.009), butC PAH did not differ (F=0.77, NS). Renal function was normal in GSD-III and GSD-IX patients. In GSD-I,C inulin (r=−0.51,P=0.03) and NAG excretion (r=−0.40,P=0.03) were inversely correlated with age, whereas albumin excretion was positively correlated with age (r=+0.41,P=0.03). RBP and calcium excretion were generally high throughout all age groups. Hyperfiltration in GSD-I is associated with renal tubular proteinuria that occurs before the onset of significant albuminuria. Deficiency of glucose-6-phosphatase within the proximal renal tubule may primarily cause tubular dysfunction, glomerular hyperfiltration being a secondary phenomenon.
Similar content being viewed by others
References
Burchell A (1992) The molecular basis of the type 1 glycogen storage diseases. Bioessays 14: 395–400
Moses SW (1991) Pathophysiology and dietary treatment of the glycogen storage diseases. J Pediatr Gastroenterol Nutr 11: 155–174
Roe TF, Thomas DW, Gilsanz V, Isaacs H, Atkinson JB (1986) Inflammatory bowel disease in glycogen storage disease type Ib. J Pediatr 109: 55–59
McCawley LJ, Korchak HM, Douglas SD, Campbell DE, Thornton PS, Stanley CA, Baker L, Kilpatrick L (1994) In vitro and in vivo effects of granulocyte colony-stimulating factor on neutrophils in glycogen storage disease type 1b: granulocyte colonystimulating factor therapy corrects the neutropenia and the defects in respiratory burst activity and Ca2+ mobilization. Pediatr Res 35: 84–90
Hers H-G, Van Hoof F, De Barsy T (1989) Glycogen storage diseases. In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds) The metabolic basis of inherited disease, 6th edn. MacGraw-Hill, New York, pp 425–452
Von Gierke E (1929) Hepato-nephromegalia glykogenica (Glykogenspeicherkrankheit der Leber und Nieren). Beitr Pathol Anat 82: 497–513
Holling HE (1963) Gout and glycogen storage disease. Ann Intern Med 58: 654–663
Chen Y-T, Coleman RA, Scheinman JI, Kolbeck PC, Sidbury JB (1988) Renal disease in type 1 glycogen storage disease. N Engl J Med 318: 7–11
Baker L, Dahlem S, Goldfarb S, Kern EFO, Stanley CA, Egler J, Olshan JS, Heyman S (1989) Hyperfiltration and renal disease in glycogen storage disease, type I. Kidney Int 35: 1345–1350
Reitsma-Bierens CC, Smith GPA, Troelstra JA (1992) Renal function and kidney size in glycogen storage disease type I. Pediatr Nephrol 6: 236–238
Obara K, Saito T, Sato H, Ogawa M, Igarashi Y, Yoshinaga K (1993) Renal histology in two adult patients with type 1 glycogen storage disease. Clin Nephrol 39: 59–64
Matsuo N, Tsuchiya Y, Cho H, Nagai T, Tsuji A (1986) Proximal renal tubular acidosis in a child with type 1 glycogen storage disease. Acta Paediatr Scand 75: 332–335
Chen Y-T, Scheinman JI, Park HK, Coleman RA, Roe CR (1990) Amelioration of proximal renal tubular dysfunction in type I glycogen storage disease with dietary therapy. N Engl J Med 323: 590–593
Restaino I, Kaplan BS, Stanley C, Baker L (1993) Nephrolithiasis, hypocitraturia, and a distal renal tubular acidification defect in type 1 glycogen storage disease. J Pediatr 122: 392–396
Cohen J, Friedman M (1979) Renal tubular acidosis associated with type III glycogenosis. Acta Paediatr Scand 68: 779–782
Nagai T, Matsuo N, Tsuchiya Y, Cho H, Hasegawa Y, Igarashi Y (1988) Proximal renal tubular acidosis associated with glycogen storage disease, type 9. Acta Paediatr Scand 77: 460–463
Sanjad SA, Kaddoura RE, Nazer HM, Ahkhatar M, Sakati NA (1993) Fanconi's syndrome with hepatorenal glycogenosis associated with phosphorylase b kinase deficiency. Am J Dis Child 147: 957–959
Task Force on Blood Pressure Control in Children (1987) Report of the second task force on blood pressure control in children—1987. Pediatrics 79: 1–25
Topping MD, Forster HW, Dolman C, Lucynska CM, Bernard AM (1986) Measurement of urinary retinol binding protein by enzymelinked immunosorbent assay and its application to the detection of tubular proteinuria. Clin Chem 32: 1863–1866
Dalton RN, Turner C (1987) A sensitive and specific method for the measurement of inulin. Ann Clin Biochem [Suppl 1]: S1-S31
Bratton AC, Marshall EK (1939) A new coupling component for sulfanimide determination. J Biol Chem 128: 537–550
Hahn-Ulrich H, Sciuk J, Bartenstein P, Kreysing P, Ullrich K (1993) Effective renal plasma flow in patients with glycogen storage disease type I. Eur J Pediatr 152: 674–676
Woods LL (1993) Mechanisms of renal hemodynamic regulation in response to protein feeding. Kidney Int 44: 659–675
Trevisan R, Nosadini R, Fioretto P, Velussi M, Avogaro A, Duner E, Iori E, Doria A, Merkel C, Valerio A, Crepaldi G (1987) Metabolic control of kidney hemodynamics in normal and insulin-dependent diabetic subjects. Effects of acetoacetic, lactic and acetic acids. Diabetes 36: 1073–1081
Johannesen J, Lie M, Kiil F (1977) Effect of glycine and glucagon on glomerular filtration and renal metabolic rates. Am J Physiol 233: F61-F66
Blankestijn PJ, Derkx FHM, Birkenhager JC, Lamberts SWJ, Mulder P, Verschoor L, Schalekamp MADH, Weber RFA (1993) Glomerular hyperfiltration in insulin-dependent diabetes mellitus is correlated with enhanced growth hormone secretion. J Clin Endocrinol Metab 77: 498–502
Hirschberg R, Brunori G, Kopple JD, Guler H-P (1993) Effects of insulin-like growth factor I on renal function in normal men. Kidney Int 43: 387–397
Schmitz G, Hohage H, Ullrich K (1993) Glucose-6-phosphate: a key compound in glycogenosis I and favism leading to hyper-or hypolipidaemia. Eur J Pediatr 152 [Suppl 1]: S77-S84
Kapelrud H, Bangstad H-J, Dahl-Jorgensen, Berg K, Hansen KF (1991) Serum Lp(a) lipoprotein concentrations in insulin dependent diabetic patients with microalbuminuria. BMJ 303: 675–678
Greene HL, Swift LL, Knapp HR (1991) Hyperlipidemia and fatty acid composition in patients treated for type Ia glycogen storage disease. J Pediatr 119: 398–403
Wolfsdorf JI, Plotkin RA, Laffel LMB, Crigler JF (1990) Continuous glucose for treatment of patients with type 1 glycogenstorage disease: comparison of the effects of dextrose and uncooked conrnstarch on biochemical variables. Am J Clin Nutr 52: 1043–1050
Debermudez L, Hayslett JP (1972) Effect of methylprednisolone on renal function and the zonal distribution of blood flow in the rat. Circ Res 31: 44–52
Friedman PA, Figuciredo JF, Maack T, Windhager EE (1981) Sodium-calcium interactions in the renal proximal convoluted tubule of the rabbit. Am J Physiol. 240: F558-F568
Smith GC, Winterborn MH, Taylor CM, Lawson N, Guy M (1994) Assessment of retinol-binding protein excretion in normal children. Pediatr Nephrol 8: 148–150
Bernard AM, Moreau D, Lauwerys R (1982) Comparison of retionl binding protein and β2-microglobulin determination in urine for the early detection of tubular proteimuria. Clin Chim Acta 126: 1–7
Sherman RL, Drayer DE, Leyland-Jones BR, Reidenberg MM (1983) N-acetyl-glucosaminidase and β2-microglobulin. Their urinary excretion in patients with renal parenchymal disease. Arch Intern Med 143: 1183–1185
Sadeghi-Nejad A, Presente E, Binkiewicz A, Senior B (1974) Studies in type I glycogenosis of the liver. The genesis and disposition of lactate. J Pediatr 85: 49–54
Kalderon B, Korman SH, Gutman A, Lapidot A (1989) Glucose recycling and production in glycogenosis type I and III: stable isotope technique study. Am J Physiol 257: E346-E353
Oberhaensli RD, Rajagopalan B, Taylor DJ, Radda GK, Collins JE, Leonard JV (1988) Study of liver metabolism in glucose-6-phosphatase deficiency (glycogen storage disease type 1a) by P-31 magnetic resonance spectroscopy. Pediatr Res 23: 375–380
Scheinman JI (1994) Glycogen storage disease. In: Holliday MA, Barratt TM, Avner ED (eds) Pediatric nephrology. Williams and Wilkins, Baltimore, pp 572–575
Fine LG, Ong ACM, Norman JT (1993) Mechanisms of tubulointerstitial injury in progressive renal diseases. Eur J Clin Invest 23: 259–265
Baker L, Kern EFO, Olshan J, Goldfarb S, Dahlem ST (1988) Pilot study of captopril in patients with renal disease associated with glycogen storage disease, type I (GSD-I). Pediatr Res 23: 388A
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Lee, P.J., Dalton, R.N., Shah, V. et al. Glomerular and tubular function in glycogen storage disease. Pediatr Nephrol 9, 705–710 (1995). https://doi.org/10.1007/BF00868717
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00868717